Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: Two-year outcomes

Ophthalmology

Volumn 117, Issue 12, 2010, Pages

  Campochiaro, Peter A ^a   Hafiz, Gulnar ^a   Channa, Roomasa ^a   Shah, Syed M ^a   Nguyen, Quan Dong ^a   Ying, Howard ^a   Do, Diana V ^a   Zimmer Galler, Ingrid ^a   Solomon, Sharon D ^a   Sung, Jennifer U ^a   Syed, Beena ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; VASCULOTROPIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; FOLLOW UP; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETINA FOVEA; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; THICKNESS; VISION; VISUAL ACUITY;

EID: 78649880482     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.03.060     Document Type: Article

References (12)

1. S. Cugati, J.J. Wang, E. Rochtchina, and P. Mitchell Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study Arch Ophthalmol 124 2006 726 732
2. R. Klein, S.E. Moss, S.M. Meuer, and B.E. Klein The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study Arch Ophthalmol 126 2008 513 518 (Pubitemid 351549845)
3. P.A. Campochiaro, G. Hafiz, and S.M. Shah Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 2008 791 799
4. D.J. Pieramici, M. Rabena, and A.A. Castellarin Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions [report online] Ophthalmology 115 2008 e47 e54
5. R.F. Spaide, L.K. Chang, and J.M. Klancnik Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion Am J Ophthalmol 147 2009 298 306
6. P.A. Campochiaro, J.S. Heier, and L. Feiner Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1102 1112
7. D.M. Brown, P.A. Campochiaro, and R.P. Singh Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
8. Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report no. 1 Arch Ophthalmol 103 1985 1796 1806
9. M.R. Hee, J.A. Izatt, and E.A. Swanson Optical coherence tomography of the human retina Arch Ophthalmol 113 1995 325 332
10. Q.D. Nguyen, S. Tatlipinar, and S.M. Shah Vascular endothelial growth factor is a critical stimulus for diabetic macular edema Am J Ophthalmol 142 2006 961 969
11. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6 Arch Ophthalmol 127 2009 1115 1128
12. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5 Arch Ophthalmol 127 2009 1101 1114